|
Chugai: Performance, Products, Pipeline and PotentialPublished by: Espicom Healthcare Intelligence Published: May. 31, 2008 - 78 Pages Table of Contents
AbstractPharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. An overview of key products and R&D is followed by a comprehensive review of the company's product portfolio and research and development pipeline by therapeutic area. In addition, supplementary appendices provide more in-depth information on financials, agreements and corporate events.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||